KIMS NSE filing

KIMS Holds 24th AGM on Aug 27, 2026, Transacts Business as Notified

The RealCase readLow impact Neutral

Krishna Institute of Medical Sciences Limited (KIMS) conducted its 24th Annual General Meeting (AGM) on August 27, 2026. The meeting transacted ordinary and special businesses, including the adoption of FY26 financial statements and approvals for loans and investments. Voting results will be shared soon.

Why it matters

The announcement details the proceedings of a routine AGM, which is a standard corporate event. It does not introduce new material information that is expected to significantly impact the company's stock price or business operations.

The market read

The announcement is a routine update about the proceedings of the Annual General Meeting and does not contain any new financial information or significant corporate actions that would sway the sentiment.

Krishna Institute of Medical Sciences Limited (KIMS) held its 24th Annual General Meeting (AGM) on August 27, 2026, commencing at 4:00 PM IST via video conferencing and other audio-visual means. The meeting was conducted in compliance with applicable regulations from the Ministry of Corporate Affairs (MCA) and the Securities and Exchange Board of India (SEBI).

Key attendees included Chairman & Managing Director Dr. Bhaskara Rao Bollineni, Executive Director Mr. Adwik Bollineni, and several Independent Directors, along with Chief Financial Officer Mr. Sachin Ashok Salvi and Company Secretary & Compliance Officer Ms. Nagajayanthi J. R. A total of 71 members attended the meeting, which concluded at 6:00 PM, including the e-voting period.

The AGM facilitated e-voting for all resolutions, with M/s. IKR & Associates appointed as the Scrutinizer for the process. The agenda included ordinary business such as the adoption of financial statements for the financial year ended March 31, 2026, and the re-appointment of a director retiring by rotation. Special businesses involved ratifying the remuneration of Cost Auditors for FY 2026-27 and seeking approval for overall limits on loans, guarantees, securities, and investments under Section 186 of the Companies Act, 2013.

Clarifications were provided to queries raised by members. The voting results, along with the Scrutinizer's Report, will be disseminated to the exchanges and published on the company's website in due course.

Filing to action

What to do with a filing like this

Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.

View original filing